SCHEMBL21712552

SCHEMBL21712552

CC(=O)c1c(-c2ccc(F)cc2)nc2ccccn12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.67
▸ KDM4E B2RXH2 3/20 0.67
▸ HPGD P15428 2/20 0.67
▸ KMT2A Q03164 1/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ MAPK1 P28482 1/20 0.53
▸ NPC1 O15118 3/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ LMNA P02545 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ TOP2A P11388 1/20 0.48
▸ MAPT P10636 1/20 0.47
▸ KCNK3 O14649 4/20 0.47
▸ KCNK9 Q9NPC2 4/20 0.47
▸ NTRK1 P04629 1/20 0.47
▸ PKM P14618 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13312213 0.88 CYP1A2 (0.67) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL14705971 0.87 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL13459301 0.85 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL25224454 0.81 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDMAPK1LMNA
SCHEMBL22627410 0.78 NPC1 (0.72) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL1786995 0.77 KMT2A (0.55) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL5740019 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL6409798 0.76 CYP1A2 (0.66) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL12651563 0.76 KMT2A (0.52) ALDH1A1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL18031314 0.75 MAP2K3 (0.54) ALDH1A1KDM4EHPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020029980-A1 SMAD3 INHIBITORS MOEXA PHARMACEUTICALS LIMITED (CN) 2020-02-13 — — WO disclosed
Send feedback